Physician profile
Gregory A Helmer
NPI 1144207572
$126,375.24
in general payments reported to CMS, 2019-2025
22 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $21K · 2021: $5,997 · 2022: $43K · 2023: $14K · 2024: $11K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Food and Beverage: $13K · Consulting Fee: $4,900 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Entertainment: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,911.31 |
| Food and Beverage | $12,984.72 |
| Consulting Fee | $4,900.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Entertainment | $107.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $35,068.17 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Medtronic Vascular, INC. | $30,095.12 | 2019-2020 | |
| Edwards Lifesciences Corporation | $17,990.21 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Evoque |
| Ancora Heart, INC. | $14,903.26 | 2022-2025 | Accucinch |
| Abbott Laboratories | $9,217.35 | 2019-2025 | Amplatzer Amulet, Mitraclip, Triclip |
| Boston Scientific Corporation | $7,044.04 | 2019-2025 | Avvigo Guidance System, Watchman Flx, General - Therapies |
| Cardiovascular Systems INC. | $4,967.14 | 2020-2022 | |
| Acist Medical Systems, INC. | $3,150.00 | 2024 | |
| Heartflow, INC. | $1,697.45 | 2021-2025 | Ffrct |
| Abiomed | $566.19 | 2019-2025 | Impella |
| Cvrx, INC. | $463.31 | 2023-2025 | Barostim Neo System |
| Teleflex LLC | $393.38 | 2022-2023 | Guideliner |
| Cardiva Medical, INC. | $210.59 | 2024-2025 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f |
| Siemens Medical Solutions USA, INC. | $205.80 | 2020-2021 | |
| Opsens INC. | $145.43 | 2019-2023 | Optowire |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corindus INC. | $117.99 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $48.08 | 2025 | Wainua |
| Cathworks, INC. | $24.65 | 2025 | Ffrangio |
| Philips North America LLC | $24.31 | 2024 | (6574) Coronary Other |
| Chiesi USA, INC. | $23.96 | 2019 | |
| Penumbra, INC. | $18.81 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Helmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.